Dizajniranje, sinteza, kinetika hidrolize i farmakodinamski profili konjugata aceklofenaka s histidinom i alaninom by ARUN RASHEED & C. K. ASHOK KUMAR
Aceclofenac (AC), a newer derivative of diclofenac, is one of the emerging NSAIDs
for the treatment of arthritis. Successful treatment of arthritis depends on maintenance
of the effective drug concentration level in the body for which a constant and uniform
supply of drug is desired. However, the problems of side effects after long-term admini-
stration of these drugs, such as irritation and ulceration of the GI mucosa, have arisen in
clinical trials (1, 2). These gastroenteropathies are generally believed to result from the
direct contact effect, which can be attributed to the combination of local irritation pro-
duced by a free carboxylic group in the molecular structure and by local blockage of
prostaglandin biosynthesis in the GI tract. Therefore, the development of new NSAIDs
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The gastrointestinal toxicity associated with aceclofenac
can be reduced by condensing its carboxylic acid group
with methyl esters of amino acids like histidine and ala-
nine to give amide linkage by the Schotten-Baumann me-
thod. Physicochemical characterization of the conjugates
was carried out by various analytical and spectral meth-
ods. The synthesized conjugates were also subjected to in
vitro hydrolysis in simulated gastric fluid (SGF) at pH
1.2, simulated intestinal fluid (SIF) at pH 7.4 and SIF+ 80
% human plasma at pH 7.4. The release of free aceclo-
fenac from histidine and alanine conjugated aceclofenac
showed negligible hydrolysis in SGF compared to SIF.
This indicated that the conjugates do not break in sto-
mach, but release aceclofenac in SIF. Both synthesized
conjugates showed excellent pharmacological response
and encouraging hydrolysis rate in SIF and SIF + 80 %
human plasma. Marked reduction of the ulcer index and
comparable increase in analgesic and anti-inflammatory
activities were obtained in both cases compared to ace-
clofenac alone. These findings suggest that the conjuga-
tes are better in action compared to the parent drug and
have fewer gastrointestinal side-effects.
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without these side-effects has been long awaited. The use of conjugates to provisionally
hide the acidic group of NSAIDs was reported providing better lipophilicity, reduced
gastric irritancy than the parent drug, improved therapeutic index through prevention
of GI irritation and bleeding, improved anti-inflammatory activity, reduced GI erosive
properties and synergistic analgesic effect (3, 4).
The NSAIDs can be conjugated with amino acids as they possess site specificity and
marked healing effect on gastric toxicity. A drug with a free carboxylic acid group can be
converted into the corresponding ester or amides of amino acid, to alter the physical
properties of the parent drug with the help of enzyme such as amidase, azo reductase
and hydrolase, serving as the in vivo reconversion site. Many amino acids also have
marked anti inflammatory activity and by using different types of amino acids, viz., non
polar, polar, acidic and basic, the drug molecule can be made more or less polar in given
solvent.
Literature reveals that many efforts have been made to synthesize conjugates of ke-
toprofen, diclofenac, flubiprofen, naproxen, ibuprofen, etc., via masking the carboxylic
acid group by forming ethyl ester, methyl ester, and glycolamide ester conjugates using
various amino acids (5–7). However, no attempts have been made so far to develop am-
ide conjugates of aceclofenac using amino acids, which is the basis of the present study.
This paper aims to synthesize amide conjugates of AC with methyl esters of histidine




Amino acids L-histidine and L-alanine were obtained from M/s Hi-Media Ltd., India,
and aceclofenac was obtained as a gift sample from Alkem Laboratories, India. Other re-
agents and solvents were of analytical grade. The reactions were monitored by TLC on
pre-coated silica G plates using iodine vapour as detecting agent. The melting points
were recorded using a melting point determination apparatus from Sigma Instrument,
India, and are uncorrected. The elemental analysis was performed using a Carlo-Erba
Model 1108 Analyzer (Italy). 1H NMR and 13C NMR spectra were recorded in DMSO on
an NMR spectrophotometer (Bruker DRX 300, USA). Chemical shifts are expressed as d
(ppm) values. IR spectra were recorded using an IR spectrophotometer (Shimadzu 8201
PC, Japan) in KBr phase and mass spectra were recorded on a mass spectrophotometer
(Jeol SX-102 (FAB) (Japan). Hydrolysis data and the drug content were determined using
an Elico UV spectrophotometer (India).
Synthesis of histidine and alanine conjugates of aceclofenac
Aceclofenac is 2-[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxyacetic acid and
the synthesis of conjugates was carried out by the Schotten Baumann method (8).
Synthesis of aceclofenac acid chloride (1). – Aceclofenac was dissolved in a minimum
amount of chloroform (0.05 mol L–1) and freshly distilled thionyl chloride (0.05 mol L–1)
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was added slowly. The mixture was refluxed for 15 h at 60–70 °C under continuous stir-
ring on a magnetic stirrer. The viscous liquid was immediately poured on a Petri dish
and it was vacuum dried to give yellow coloured crude aceclofenac acid chloride (1).
Synthesis of methyl ester hydrochlorides of L-histidine and L-alanine (2a,b). – Freshly dis-
tilled thionyl chloride (0.05 mol L–1) was slowly added to methanol (100 mL) with cool-
ing and histidine (2) (0.1 mol L–1) was added. The mixture was refluxed for 6–8 h at
60–70 °C under continuous stirring on a magnetic stirrer. Excess thionyl chloride and
solvent were removed under reduced pressure giving crude histidine methyl ester hy-
drochloride. It was treated with a 20 mL portion of cold ether at 0 °C. The resulting solid
product was collected and dried under vacuum. It was re-crystallized from hot metha-
nol by slow addition of 15–20 mL ether followed by cooling at 0 °C. The crystals were
collected on the following day and washed twice with an ether/methanol mixture (5:1
ratio) followed by pure ether and dried under vacuum to give pure histidine methyl es-
ter hydrochloride (2a). The same procedure was followed to synthesize alanine methyl
ester hydrochloride (2b) (9).
Synthesis of aceclofenac conjugates with methyl esters of L-histidine and L-alanine (3a,b).
– Ice-cold, aqueous sodium hydroxide solution (5 %) was placed into a 250 mL beaker
and methyl ester of L-histidine or L-alanine hydrochloride (0.05 mol L–1) was added.
The reaction mixture was mechanically stirred for 30 min at room temperature, then the
beaker was transferred to an ice bath kept on a mechanical stirrer, maintaining the tem-
perature at 10 °C. Aceclofenac acid chloride (0.01 mol L–1) was added in small portions
under continuous stirring for 7–8 h. The solid that separated out was filtered off. The
crude conjugate was re-crystallized from methanol. Schematic representations of the
synthesis of histidine conjugated aceclofenac (3a) and alanine conjugated aceclofenac
(3b) are given in Scheme 1.
Characterization of synthesized conjugates
The structure of synthesized compounds was established by elemental analysis, 1H
NMR, 13C NMR, and FTIR spectral methods (Tables I and II). The purity was determi-
ned by TLC using silica gel and the physicochemical parameters were determined.
Protein binding studies (10). – A solution of the synthesized conjugate (10 mg mL–1)
was prepared in phosphate buffered saline (PBS, pH 7.4). 100 mL of this solution was
placed in a beaker. The cellophane membrane (molecular mass cut off in the range of
10000–12000 Da obtained from Hi-Media, India) was first washed with distilled water
and then with buffer solution (pH 7.4). It was tied at the opening end of a dialysis tube;
the dialysis tube containing (6 %) egg albumin was dipped into the drug solution and
covered. The whole assembly was placed on a magnetic stirrer and set at low revolu-
tions per minute. The temperature was maintained at 37 ± 0.5 °C. After each 1 h, 1 mL of
the PBS containing drug solution was replaced with fresh 1 mL of PBS. The withdrawn
sample was further diluted with 1 mL phosphate buffer and the concentration of the co-
njugate was estimated using a spectrophotometer at 230 nm.
Hydrolysis rate determination of synthesized conjugates (11). – In vitro hydrolysis studies
of synthesized conjugates were carried out in simulated gastric fluid (SGF) at pH 1.2,
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simulated intestinal fluid (SIF) at pH 7.4 and SIF + 80 % human plasma at pH 7.4. A so-
lution of 10 mg of conjugate was prepared in 90 mL of SIF (pH 7.4) or SGF (pH 1.2). An
aliquot of 15 mL of this solution was withdrawn repeatedly and kept in test tubes main-
tained at 37 ± 0.5 °C. At a definite time interval (0.5 h, 1–8 h), an aliquot was withdrawn
from different test tubes and was transferred to micro centrifuge tubes, followed by ad-
dition of methanol to make up the volume. The tubes were placed in a freezing mixture
in order to arrest further hydrolysis, followed by vortexing at high speed for 5 min. Af-
ter vortexing, the tubes were centrifuged at high speed (3000 rpm) for 5 min. 5 mL of
clear supernatant obtained from each tube was measured by a spectrophotometer for the
amount of free aceclofenac released after the hydrolysis of prodrugs in SGF, SIF and SIF
+ 80 % human plasma at 230 nm. The kinetics of hydrolysis was monitored by the in-
crease of free drug concentration with time and the order of the reaction and half-life
(t1/2) were also calculated. The rate of hydrolysis was calculated using the equation:
kH = (2.303/t) log (a/a–x)
where kH represents the hydrolysis constant, t is the time in min, a is the initial conjugate
concentration, x is the amount of conjugate hydrolyzed and (a–x) is the amount of the re-
maining conjugate.
Pharmacological evaluations
Aceclofenac as well as the synthesized conjugates were evaluated for analgesic,
anti-inflammatory and ulcerogenic activity. Histopathology and a comparative study were
also performed. Test compounds and standard drugs were administered in the form of a
suspension (1 % carboxymethylcellulose as vehicle) by the oral route of administration
for analgesic and anti-inflammatory studies, but intraperitoneally as suspension in 2 %
(m/V) acacia for ulcerogenicity studies. Wistar albino rats (100–200 g) of four groups, in-
cluding a control and a standard group, with six animals each were selected. The se-
lected animals were housed in acrylic cages under standard environmental conditions at
25 ± 2 °C, relative humidity of 45–55 %, in a well ventilated room maintained at a 12:12 h
light:dark cycle, and were fed a standard rodent diet and water ad libitum. All the ani-
mals were acclimatized for a week before experiment. All animal experiments were car-
ried out according to the guidelines of the Committee for the Purpose of Control of Ex-
periments on Animals and Approval of the Institutional Animal Ethics Committee, Sree
Vidyanikethan College of Pharmacy, Tirupati, India was obtained.
Anti-inflammatory activity. – The anti-inflammatory activity was determined by the
hind paw oedema method (12) using carrageenean as phlogistic agent. Wistar albino rat
were divided into four groups, of six rats each, including a control and a standard group.
The initial right hind paw volume was measured using a plethysmometer without con-
jugate administration. The conjugate, 10 mg kg–1 body mass, was administered orally in
a 1 % suspension of sodium carboxymethylcellulose (containing 0.1 %, m/V, of conju-
gate). After 30 min of conjugate administration, the carrageenean (0.1 mL, 1 %, m/V solu-
tion in normal saline was injected into the planta surface of the right hind paw of each
animal. The volume of the right hind paw of the albino rat was measured after 2, 4 and 6 h.
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Analgesic activity. – The analgesic activity was determined by the thermal stimulus
using the tail flick method (13). An analgesiometer was used to determine the pain thres-
hold of albino rats. Cold water was circulated through the water jackets of the instru-
ment to avoid heating of the area around the hot wire. The rat (100–200 g) was placed in
a holder through which its tail was protruded out. The reaction time was recorded at 30
min, 1, 2 and 3 h after the treatment and the cut-off time was 9 s. The normal reaction
time, i.e., the time taken to flick the tail was noted. Animals showing delayed response
were rejected. The conjugate (dose of each conjugate was calculated to be equivalent to
10 mg kg–1 body mass) was administered orally in a 1 % suspension of sodium carboxy-
methylcellulose.
Ulcerogenicity index. – Gastrointestinal toxicity of the synthesized conjugates was
measured and compared with the parent drug by measuring the ulcer index (14). The
control group was administered only a 2 % (m/V) acacia suspension intraperitoneally.
Measured volume of the suspension containing a dose equivalent to 10 mg kg–1 of body
mass of AC was administered orally to the test group daily for 5 days. The rats (130–150
g) were fasted after administration of the last dose, then they were sacrificed by decapi-
tation and the stomach was removed, opened and washed with distilled water. Lesions
on the gastric mucosa were counted by visual examination using a binocular magnifier.
Ulcers larger than 0.5 mm were recorded. The mean ulcer index (UI) was calculated ac-
cording to severity of gastric mucosal lesions graded as: grade 1 – less than 1-mm ero-
sions, grade 2 – 1-2-mm erosions, grade 3 – more than 2-mm erosions.
The UI was calculated as: UI = [1 ´ (number of lesions of grade 1) + 2 ´ (number of
lesions of grade 2) + 3 ´ (number of lesions of grade 3)]/10.
Histopathological studies. – Histopathological studies of rat stomach were carried out
using haemotoxylin and eosin stain (15) at the Pathology Department, Sri Venkateswara
Veterinary University, Tirupati, India. Stomach tissues were removed from the rats and
fixed in 10 % normal saline for at least 48 h. These were then processed routinely and the
tissues were embedded in paraffin wax. Histological sections were cut at 5–6 µm and
stained with standard haematoxylin and eosin. The lesions observed were assessed for
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subsequent mucosal atrophy, the presence of inflammatory cells in the wall, oesinophils,
lymphocytes and plasma cells. Photomicrographs of representative lesions were taken at
various magnifications on a Zeiss optical microscope, Stemi 2000-C (Germany), with a
resolution of 10 ´ 45X, with a trinocular camera attached.
Statistical analysis
Statistical analysis of the pharmacological activity data of the synthesized prodrugs
on animals was evaluated using a one-way analysis of variance (ANOVA). Student’s
t-test was applied to express the significance. Data are expressed as mean ± SD (stan-
dard deviation).
RESULTS AND DISCUSSION
The conjugates 3a N-[b-immidazole-3-yl-a-(methylpropionate)]2[((2,6-dichloro phe-
nyl)aminophenylacetoxyacetamide)] and 3b N-(methylpropionate)2[((2,6-dichlorophe-
nyl)aminophenylacetoxyacetamide)] were prepared from methyl esters of alanine and
histidine and acid chlorides of aceclofenac (Scheme 1).
The conjugates 3a and 3b were subjected to solubility, physicochemical characteri-
zation, protein binding and hydrolytic studies. The solubility studies showed that 3a
and 3b were highly soluble in methanol, slightly soluble in NaOH and insoluble in 0.1
mol L–1 HCl. They showed moderate to high solubility in chloroform, ethanol and ace-
tone. Higher solubility of the standard drug AC (1) is mainly due to the presence of free
carboxylic acid, which forms sodium salt and makes the compound ionic. But, the conju-
gates 3a and 3b, which show moderate to high solubility in organic solvents, indicate
lipophilic behaviour. Physicochemical properties of the synthesized conjugates are shown
in Table I. Results of the elemental analysis of synthesized conjugates were in all cases
within ± 0.4 % of theoretical values and confirmed the desired structure. The IR, 1H
NMR, 13C NMR and mass spectral data of synthesized conjugates are shown in Table II.
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Fig. 1. Comparative pattern of hydrolysis of: a) 3a and 3b in SIF, b) 3a and 3b in SIF + 80 % plasma.
The half-life (t1/2) of conjugate 3a in SIF was found as 4.5 h and that of 3b as 4.4 h.
The comparative pattern of hydrolysis of these conjugates in SIF (pH 7.4) is shown in
Fig. 1a. The amount of AC regenerated by hydrolysis of 3a and 3b was found to be 79
and 72 %, respectively. The comparative pattern of hydrolysis of conjugates in SIF + 80 %
human plasma is shown in Fig. 1b. The amount of AC regenerated by hydrolysis of 3a
and 3b was found to be 92 and 95 %, respectively. Satisfactory hydrolysis of the conju-
gates was observed in SIF and very encouraging hydrolysis in SIF + 80 % human
plasma. The latter is due to the presence of amidase in plasma. Thus, the hydrolytic ki-
netics study revealed that both 3a and 3b followed first-order kinetics (Fig. 2). The per-
centage protein binding of conjugates 3a and 3b was found to be 64 and 72 % respec-
tively. The conjugates showed comparatively low protein binding compared to the
standard drug, whose value is 75 %. This increases the availability of conjugates for hy-
drolysis in plasma and the required dose will be lower.
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Pharmacological investigations of the synthesized conjugates were carried out for
anti-inflammatory, analgesic and ulcerogenic activities (Table III). The dose of 3a and 3b
administered was equivalent to 10 mg kg–1 body mass of the parent drug AC.
The anti-inflammatory activity obtained after 2 and 6 h of administration of the
standard drug AC were found to be 61 and 45 % whereas for conjugates 3a and 3b they
were 67 and 75 % after 6 h (Table III). The anti-inflammatory activity of free AC decreas-
ed with time while that of its conjugates increased with time due to their higher bio-
availability compared to the parent drug. Maximum anti-inflammatory activity of conju-
gates 3a and 3b was observed after 6 h and remained practically constant up to 8 h. The
statistical significance was tested by one way ANOVA followed by Dunnett’s test. The
data showed significantly higher anti-inflammatory activity of 3a and 3b compared to
AC (standard drug) after 4 and 6 h.
The analgesic activity of synthesized conjugates 3a and 3b after 1 h of administra-
tion was found to be 28 and 31 %, respectively while that of AC was 60 % (Table III). Af-
ter 4 h of drug administration, the analgesic activity of the parent drug was reduced to
48 %, while that of 3a and 3b increased to 52 and 45 %, respectively. This revealed that
the analgesic activity of AC decreased with time, but the synthesized products showed
sustained analgesic activity. This may be due to higher bioavailability of the synthesized
conjugates.
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Fig. 2. First-order hydrolysis plot of
3a and 3b in SIF + 80 % plasma.








2 h 4 h 6 h 1 h 2 h 3 h 4 h
AC 62 ± 2 50 ± 1 45 ± 1 60 ± 2 62 ± 1 52 ± 1 48 ± 2 28 ± 2
3a 58 ± 1c 64 ± 2c 67 ± 1c 28 ± 1c 50 ± 1c 51 ± 1c 52 ± 1c 6 ± 1c
3b 64 ± 1c 68 ± 1c 75 ± 2c 31 ± 2c 51 ± 2c 46 ± 1c 45 ± 1c 5 ± 1c
Control animals were administered orally 1 % carboxymethylcellulose.
b Mean ± SD, n = 6.
c Significantly different vs. AC, p < 0.05.
The ulcer index of the synthesized conjugates was recorded to observe the extent of
gastrointestinal side effects (Table III). The mean ulcer index of the standard drug AC
was found to be 28 and for the conjugates 3a and 3b 6 and 5, respectively. The mini-
mized side effect obtained in the conjugates might be due to inhibition of the direct con-
tact of the carboxylic acid group of the drug to the gastric mucosa which is mainly re-
sponsible for the damage.
The histopathological findings are summarized as follows. Gastric tissues were in-
vestigated microscopically and the tissue samples of control group rats showed normal
histological findings (Fig. 3). Microscopic investigation of the AC group revealed a focal
erosive area in gastric mucosa and a zone (clear zone) in the basal regions of the gastric
glands stained pale. This zone was parallel to the surface of the stomach lumen. In this
zone, the structures of the gland were destroyed. They had disintegrated from the basal
lamina and fallen into the lumen. The nuclei of these cells became smaller and dense,
and their cytoplasms were stained as dark eosinophilic bodies. Small hemorrhagic areas
and patches of inflammatory cell infiltrations were present in the lumen of the glands
and lamina propria. Normal histological findings were displayed for both 3a and 3b re-
vealing that the conjugates are not producing any ulceration in the gastric region.
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Fig. 3. Histopathological studies of conjugates: a) healthy control, b) ulcer control showing mucosal
injury characterized by AC and massive mucosal infiltration of inflammatory cells, c) treated with




Histidine and alanine containing aceclofenac amide conjugates were successfully syn-
thesized and the structure was confirmed based on their spectral analysis. Both 3a and
3b showed an excellent pharmacological response and encouraging hydrolysis rate in
SIF + 80 % of human plasma. Lower protein binding of the conjugates increased its ava-
ilability for hydrolysis in plasma and thus resulted in a lower dose requirement. Increa-
sed anti-inflammatory and analgesic activities as well as reduction of the ulcer index of
the conjugates were observed when compared to the parent drug. The histopathological
findings revealed that there was limited ulcer formation in the stomach by the conju-
gates. On the basis of the above observations, it is concluded that these conjugates can
be successfully applied to attain the goal of minimized gastro-intestinal toxicity without
loss of the desired anti-inflammatory and analgesic activity of the drug.
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S A @ E T A K
Dizajniranje, sinteza, kinetika hidrolize i farmakodinamski profili
konjugata aceklofenaka s histidinom i alaninom
ARUN RASHEED i C. K. ASHOK KUMAR
Gastrointestinalna toksi~nost aceklofenaka mo`e se umanjiti kondenzacijom karbok-
silne skupine aceklofenaka s metilnim esterima aminokiselina poput histidina i alanina,
pri ~emu se stvaraju nove amidne veze po Schotten-Baumannovoj metodi. Fizikokemij-
ska karakterizacija konjugata provedena je razli~itim analiti~kim i spektralnim metodama.
Nadalje, pra}ena je hidroliza sintetiziranih konjugata in vitro u simuliranoj gastri~noj te-
ku}ini (SGF) pri pH 1,2, simuliranoj intestinalnoj teku}ini (SIF) pri pH 7,4 i simuliranoj
intestinalnoj teku}ini s 80 % humane plazme pri pH 7,4. Osloba|anje aceklofenaka iz
konjugata s histidinom, odnosno alaninom, bilo je zanemarivo u SGF-u, u odnosu na
osloba|anje u SIF-u. To ukazuje da su konjugati stabilni u `elucu, dok se u SIF-u iz njih
osloba|a aceklofenak. Oba konjugata daju izvrstan farmakolo{ki odgovor i zadovolja-
vaju}i stupanj hidrolize u SIF-u i smjesi SIF-a i humane plazme. Oba konjugata pokazala
su zna~ajno smanjenu ulcerogenost i poja~ano analgetsko i protuupalno djelovanje u od-
nosu na aceklofenak. Rezultati ukazuju na prednost konjugata u odnosu na samu ljeko-
vitu tvar.
Klju~ne rije~i: aceklofenak, aminokiselinski konjugat, prolijekovi, farmakokinetika, ulcerogenost
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